Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Ensysce Biosciences
Watchlist
ENSC: NDA Submission in Sight
Equity Bottom-Up
279 Views
11 Mar 2025 16:00
Issuer-paid
Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...
What is covered in the Full Insight:
Introduction
Company Financials
Clinical Developments
FDA Designation and Recognition
Conclusion and Outlook
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 7-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Equity Bottom-Up
Philippines
Event-Driven
Sell / Short Ideas
Asia Event-Driven
Unpaywalled Insights
South Korea
India
United States
Trending Insights
More »
UK: Slowdown Softened In Q2
S&P/​​​​​​​​​ASX Index Rebalance Preview (Sep 25): Potential Changes if Methodology Is Updated
Value Unlock SG: Value Creation Via Corporate Action. May the Wind Carry Many More Sails
Quiddity Leaderboard CSI 300/​​500 Dec25: Trade Moving in the Right Direction; Large Flows Expected
Kangji Medical (9997 HK): Q&A With The FA
Top Unpaywalled Insights
More »
[IO Technicals 2025/33] China Woes Deepen, Bearish Momentum Grips Iron Ore
Tradesmen's Collective: Fixing the Trades with Tech, Transparency & Boots-on-the-Ground
VEON 2Q25: Solid Digital Non-Telco Products Uplift, Kyivstar Listing in Focus
[IO Technicals 2025/32] Bullish Momentum Builds
Grab Holdings (GRAB US) - Harvesting Sequentially
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
ENSC: NDA Submission in Sight
11 Mar 2025
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.56.1
x